Skip to main content
Fig. 2 | Substance Abuse Treatment, Prevention, and Policy

Fig. 2

From: The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial

Fig. 2

A linear prediction of changes in FSS-9 sum scores from baseline to EOT12 (intention-to-treat analysis) (N = 276). Legends: The figure displays the linear prediction (fixed portion) including 95% confidence intervals of FSS-9 sum score (ΔFSS-9 sum score) at baseline and from baseline (prior to HCV treatment) to EOT12 for integrated and standard HCV treatment groups. The FSS-9 sum score ranges from 9 points, no fatigue, to 63 points, worst fatigue. EOT12: 12 weeks after the end of HCV treatment; FSS-9: Nine-item fatigue severity scale; HCV: Hepatitis C virus

Back to article page

Substance Abuse Treatment, Prevention, and Policy

ISSN: 1747-597X